SAB Meet and Greet: Welcome Dr. Beaudet
Barb Bailus, PhD Our next new scientific advisory board (SAB) member could be considered the grandfather of Angelman syndrome (AS), Dr. Art Beaudet. Dr. Beau
SAB Meet and Greet: Welcome Dr. Yu
Barb Bailus, PhD Today we start a series of posts to introduce our newest FAST Scientific Advisory Board members; it is an honor to welcome such an amazing g
Taking Flight: A Look Toward the Current and Future Clinical Trials for Angelman Syndrome
Barb Bailus PhD Hello everyone, in celebration of International Angelman Syndrome Day last week, we are going to take a glance into the future and review sev
FAST Welcomes New Chief Scientific Communications Reporter, Barb Bailus PhD
Understand the Power of Your Donations Hello fellow Angelman Community, as this is my first “official” blog I am going to take a moment and introduce mys
Gene Therapy 101
written by Allyson Berent, DVM DACVIM When we refer to gene therapy in Angelman Syndrome (AS), we are typically referring to a “viral delivery” or “vir
UC DAVIS Researchers hone in on Angelman Syndrome Treatment
FAST (Foundation for Angelman Syndrome Therapeutics) has funded two research labs at the University of California, Davis (UC Davis) to further investigation
Towards Therapeutics – The FIRE Team Series, Part III
Read more about the exciting work that has earned the Segal Lab $1.1 Million for research.
Towards Therapeutics – The FIRE Team Series, Part II
RDr. Dindot’s 3 goals, which have been the focus of his AS research through the FIRE initiative, are;
Mechanisms regulating imprinting of UBE3A in ne
Ketone esters for the treatment of seizures in AS – clinical trial coming soon!
Medical foods as an effective approach to management of Angelman Syndrome The following is a recount of a presentation about using therapeutic ketones (KES)
FAST Research Series
Read our regular series summarizing lectures presented on Friday December 4th, 2015, the first day of the 2015 FAST Global Summit. This series will be focuse